⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024Open Access

Supplementary Figure S7 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer

Lars Sivars Cecilia Jylhä Ylva Crona Guterstam Mark Zupancic Britta Lindqvist Magnus Nordenskjöld Emma Tham Kristina Hellman

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S7. Number of copies of ctHPV DNA at different timepoints for all patients (n = 13) who experienced disease progression at early follow-up or tumor evaluation or shortly thereafter and thus were not deemed to have had complete response to treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sivars et al. (2024) studied this question.

synapsesocial.com/papers/68e62195b6db6435875b3772 https://doi.org/10.1158/1078-0432.26134585

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S7 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer2024
2Supplementary Figure S8 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer2024
3Supplementary Figure S8 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer2024
4Supplementary Figure S6 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer2024
5Supplementary Figure S6 from Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer2024